newsfilter
← Latest News
Earnings Call Transcripts·

Topline Clinical Results from the DELIVER Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy - DYNE THERAPEUTICS INC

Good morning and welcome to the Dine Therapeutics call to review the top-line clinical results from the DELIVER trial in Duchenne muscular dystrophy. Today's call will be hosted by John Cox, President and CEO, and Doug K

Company
DYNE THERAPEUTICS INC
Keywords
DYNE THERAPEUTICS INC